mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.09 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.09 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.09 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.09 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |